Mycobacterium kansasii infections in patients with cancer

Kalen L. Jacobson; Issam Raad; Kenneth V.I. Rolston; Estella Whimbey; Herman I. Libshitz; Jeffrey Tarrand; Ramón Teira

doi:10.1086/313801

Mycobacterium kansasii infections in patients with cancer

Kalen L. Jacobson, Issam Raad, Kenneth V.I. Rolston, Estella Whimbey, Herman I. Libshitz, Jeffrey Tarrand, Ramón Teira

Research output: Contribution to journal › Article › peer-review

22 Scopus citations

Abstract

Mycobacterium kansasii was isolated from 25 patients with cancer who were cared for at the University of Texas M. D. Anderson Cancer Center (Houston) from January 1987 through December 1996. Two patients (8%) had disseminated disease, and 23 (92%) had pleuropulmonary isolates only. Signs and symptoms of mycobacterial infection at the time of diagnosis were often minimal or absent despite substantial radiographically evident involvement. The infections responded well to rifampin-based antimycobacterial regimens. M. kansasii is an infrequent but serious cause of pulmonary and, occasionally, disseminated disease in patients with cancer.

Original language	English (US)
Pages (from-to)	965-969
Number of pages	5
Journal	Clinical Infectious Diseases
Volume	30
Issue number	6
DOIs	https://doi.org/10.1086/313801
State	Published - 2000

ASJC Scopus subject areas

Microbiology (medical)
Infectious Diseases

Access to Document

10.1086/313801

Cite this

@article{67f82338cda141ff8e6bdc0778a4913a,

title = "Mycobacterium kansasii infections in patients with cancer",

abstract = "Mycobacterium kansasii was isolated from 25 patients with cancer who were cared for at the University of Texas M. D. Anderson Cancer Center (Houston) from January 1987 through December 1996. Two patients (8%) had disseminated disease, and 23 (92%) had pleuropulmonary isolates only. Signs and symptoms of mycobacterial infection at the time of diagnosis were often minimal or absent despite substantial radiographically evident involvement. The infections responded well to rifampin-based antimycobacterial regimens. M. kansasii is an infrequent but serious cause of pulmonary and, occasionally, disseminated disease in patients with cancer.",

author = "Jacobson, {Kalen L.} and Issam Raad and Rolston, {Kenneth V.I.} and Estella Whimbey and Libshitz, {Herman I.} and Jeffrey Tarrand and Ram{\'o}n Teira",

year = "2000",

doi = "10.1086/313801",

language = "English (US)",

volume = "30",

pages = "965--969",

journal = "Clinical Infectious Diseases",

issn = "1058-4838",

publisher = "Oxford University Press",

number = "6",

}

TY - JOUR

T1 - Mycobacterium kansasii infections in patients with cancer

AU - Jacobson, Kalen L.

AU - Raad, Issam

AU - Rolston, Kenneth V.I.

AU - Whimbey, Estella

AU - Libshitz, Herman I.

AU - Tarrand, Jeffrey

AU - Teira, Ramón

PY - 2000

Y1 - 2000

N2 - Mycobacterium kansasii was isolated from 25 patients with cancer who were cared for at the University of Texas M. D. Anderson Cancer Center (Houston) from January 1987 through December 1996. Two patients (8%) had disseminated disease, and 23 (92%) had pleuropulmonary isolates only. Signs and symptoms of mycobacterial infection at the time of diagnosis were often minimal or absent despite substantial radiographically evident involvement. The infections responded well to rifampin-based antimycobacterial regimens. M. kansasii is an infrequent but serious cause of pulmonary and, occasionally, disseminated disease in patients with cancer.

AB - Mycobacterium kansasii was isolated from 25 patients with cancer who were cared for at the University of Texas M. D. Anderson Cancer Center (Houston) from January 1987 through December 1996. Two patients (8%) had disseminated disease, and 23 (92%) had pleuropulmonary isolates only. Signs and symptoms of mycobacterial infection at the time of diagnosis were often minimal or absent despite substantial radiographically evident involvement. The infections responded well to rifampin-based antimycobacterial regimens. M. kansasii is an infrequent but serious cause of pulmonary and, occasionally, disseminated disease in patients with cancer.

UR - http://www.scopus.com/inward/record.url?scp=0034463369&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034463369&partnerID=8YFLogxK

U2 - 10.1086/313801

DO - 10.1086/313801

M3 - Article

C2 - 10880318

AN - SCOPUS:0034463369

SN - 1058-4838

VL - 30

SP - 965

EP - 969

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

IS - 6

ER -

Mycobacterium kansasii infections in patients with cancer

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this